UBS Group Has Lowered Expectations for Pediatrix Medical Group (NYSE:MD) Stock Price
Pediatrix Medical Group (NYSE:MD – Get Free Report) had its price objective dropped by stock analysts at UBS Group from $18.50 to $16.00 in a research note issued on Monday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. UBS Group’s target price would suggest a potential upside of 11.03% from the stock’s […]
Pediatrix Medical Group (NYSE:MD – Get Free Report) had its price objective dropped by stock analysts at UBS Group from $18.50 to $16.00 in a research note issued on Monday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. UBS Group’s target price would suggest a potential upside of 11.03% from the stock’s […]
